Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States

被引：30
作者：
Coleman, Craig I. [1 ]
Tangirala, Muralikrishna [2 ]
Evers, Thomas [3 ]
机构：
[1] Univ Connecticut, Sch Pharm, 69 North Eagleville Rd, Storrs, CT 06269 USA
[2] Bayer HealthCare Pharmaceut, Whippany, NJ USA
[3] Bayer Pharrna AG, Wuppertal, Germany
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 212卷
关键词：
Medication adherence; Rivaroxaban; Dabigatran; Proportion of days covered; Non-valvular atrial fibrillation; WARFARIN;
D O I：
10.1016/j.ijcard.2016.03.051
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：171 / 173
页数：3
相关论文
共 11 条
[1]  
[Anonymous], 2014, DAN GROUP
[2]   Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research [J].
Austin, Peter C. .
COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION, 2009, 38 (06) :1228-1234
[3]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[4]   Effect of dosing frequency on chronic cardiovascular disease medication adherence [J].
Coleman, Craig I. ;
Roberts, Matthew S. ;
Sobieraj, Diana M. ;
Lee, Soyon ;
Alam, Tawfikul ;
Kaur, Rajbir .
CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (05) :669-680
[5]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[6]  
D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
[7]  
2-B
[8]   A New Risk Scheme to Predict Warfarin-Associated Hemorrhage The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study [J].
Fang, Margaret C. ;
Go, Alan S. ;
Chang, Yuchiao ;
Borowsky, Leila H. ;
Pomernacki, Niela K. ;
Udaltsova, Natalia ;
Singer, Daniel E. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (04) :395-401
[9]   European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation [J].
Heidbuchel, Hein ;
Verhamme, Peter ;
Alings, Marco ;
Antz, Matthias ;
Hacke, Werner ;
Oldgren, Jonas ;
Sinnaeve, Peter ;
Camm, A. John ;
Kirchhof, Paulus .
EUROPACE, 2013, 15 (05) :625-651
[10]   Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation [J].
Lane, Deirdre A. ;
Lip, Gregory Y. H. .
CIRCULATION, 2012, 126 (07) :860-865
12